ep ahead street retract
life scienc tool diagnost decreas target price
ep ahead consensu ep match
estim higher revenu off-set lower profit factor line
ad importantli withdrew guidanc despit
note livestock industri face unpreced disrupt demand
product due pandem lower ep
increment expect covid-rel headwind
price move lower view
revenu in-lineanim ahead profit weaker revenu rose
line view includ encouragingli better anim health experi vs estimate
partial off-set weaker perform across miner nutrit vs estimate
perform product vs estimate org basi anim health sale
improv includ declin mfa asf china new regulatori
chang partial off-set domest latam strength nutrit spec
line view driven domest poultri dairi well osprey acquisit
segment growth ad million vaccin vs estimate
robust intenational demand poultri vaccin adjuv sale gross margin improv
bp bp plan primarili mix sg rose bp bp plan
net/net ebitda margin deterior bp bp plan gener
million cash y/i cash reserv stand million net debt/ebtida
reiter neutral share ytd vs share held
reason well encourag solid growth pahc all-
import higher-margin anim health segment view may edg lower
limit clariti late fiscal year addit covid-rel disrupt
product capac profit remain transit year necessari
invest support futur growth includ pipelin develop facil expans
sale forc initi new product commerci await greater clariti
success front call commentari focu impact qtd demand
trend asf outlook trade dynam fx new develop efforts/cost risk shift
regulatori demand environ
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
lead manufactur anim health product concentr
product anim product prevent control treat diseas
enhanc health nutrit overal product livestock
challeng relat antibiot use greater expect ramp faster-
grow subsector anim health vaccin nutrit specialti
favor epidemiolog weather macroeconom trend
influenc underli util trend consider pick
us intern livestock fundament demand
grey sky valuat assum harsher expect
regulatori challeng global use antibiot medicin feed addit
weak global livestock demand
 close
latest result indic eas pressur across all-import faster-grow higher-
margin anim health categori off-set weak miner nutrit perform
product area less relev declin mfa eas continu asf
headwind china partial off-set strong poultri cattl demand latin
america nutrit specialti line view despit lower-
than-expect osprey contribut segment growth ad million note
strength domest dairi poultri vaccin vs estimate rebound
easi comp lap loss domest distribut arrang well strong
conjunct print withdrew guidanc previous call revenu
growth flat includ contribut ep
uncertainti regard scope protein product disrupt relat
pandem note sale quarter-to-d trend rel in-lin
expect anticip declin relat reduc process facil capac
lead reduct amount anim dairi produc demand disrupt
price declin across protein speci
addit note remain transit year invest need
support futur growth pipelin develop remind announc
enter agreement develop canin lyme diseas vaccin notabl entranc
faster-grow companion anim speci segment recent
announc develop potenti vaccin african swine fever
introduc new vaccin deliveri system consequ incur increment cost
associ effort along potenti develop effort partnership
focus nutrit vaccin segment across product companion anim
speci group compani target contribut effort materi longer
term make hard-hit catalyst longer term natur
figur quarterli revenu growth segment
anim health revenu
s/other revenu segment revenu fell slightli better
estim continu reduct demand china relat asf
partial off-set strong poultri cattl demand latin america
expect sale growth mfa product ex china longer term asf
recent regulatori develop china disproport offset
nutrit specialti revenu growth nutrit specialti
line view osprey contribut strength poultri
dairi demand like drive omnigen sale remind launch updat
omnigen product januari target large-scal dairi farm increas
milk product cow addit provid immun system support
note osprey contribut roughli half segment growth million
slightli smaller contribut anticip impli organ nutrit specialti growth
organ anim health segment growth
vaccin revenu vaccin sale increas estimate
driven primarili strong intern demand poultri vaccin adjuv
miner nutrit revenu
miner nutrit revenu view vs estimate reduc asp driven
declin raw materi price partial off-set higher volum note miner nutrit
pahc least profit busi expect meaning growth
driver extend histori busi industry-lead presenc extens
relationship across suppli chain help unlock cross sell opportun
perform product revenu
perform product revenu growth fell short flat growth vs estimate driven
lower volum person care ingredi deemphas perform
product busi past sever year expect continu deemphas
segment opportunist divestitur go forward profit within segment remain
rel low ebitda margin greater focu higher margin anim
busi bode well profit profil longer term
quarter gener million cash cash reserv stand
million capit deploy strategi remain focus de-lever dividend
tuck-in acquisit partnership supplement growth
expect total revenu growth reflect growth anim health
miner nutrit growth perform product ebitda
margin bp lower due aforement increment invest covid-rel
margin pressur lower revenu view partial off-set lower interest tax expens
contribut osprey drive ep growth
expect ep grow normal revenu growth
assum continu covid-rel revenu margin headwind first half
year off-set normal stabil fundament across us livestock industri
second half year well build momentum cross-market intern
strategi forecast ebitda margin expans bp better product mix
oper effici
ep current trade slight discount histor averag
view justifi given slower growth profil price target
base multipl ep
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
